Neurelis Announces Closing of Series B Financing Round for Intranasal Diazepam Spray
Neurelis, Inc. said today that it closed a Series B financing round, led by HBM Healthcare Investments. Other investors included LYZZ Capital, which previously led a Series A funding round…
Share